Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

• Novartis AG
• Amgen Inc.
• AbbVie Inc.
• Bayer AG
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.
• Bausch Health Companies Inc.
• F. Hoffmann-La Roche Ltd.
• MeiraGTx Holdings plc
• Oxurion NV